Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma

Background: We investigated acute adverse events in patients with brain metastases (BMs) of anaplastic lymphoma kinase-rearranged (ALKr) non-small cell lung cancer (NSCLC) treated with both cranial radiotherapy and tyrosine kinase inhibitors (TKIs) of ALK. Patients and Methods: Acute AEs were retros...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Autores principales: NAKASHIMA, TAKAAKI, NONOSHITA, TAKESHI, HIRATA, HIDENARI, INOUE, KOUJI, NAGASHIMA, AKIRA, YOSHITAKE, TADAMASA, ASAI, KAORI, SHIOYAMA, YOSHIYUKI
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984098/
https://ncbi.nlm.nih.gov/pubmed/31882485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11767
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares